Literature DB >> 27338943

In vivo proinflammatory activity of generations 0-3 (G0-G3) polyamidoamine (PAMAM) nanoparticles.

Isabelle Durocher1, Denis Girard2.   

Abstract

OBJECTIVE AND
DESIGN: The aim of this study was to determine whether different generations (G) polyamidoamine (PAMAM) dendrimers possess proinflammatory activities in vivo. MATERIAL OR
SUBJECTS: Several hundred female CD-1 mice were used to test four different PAMAM dendrimers using the murine air pouch model. TREATMENT: Mice received appropriate negative and positive controls or G0-G3 PAMAM nanoparticles at 100 and 500 µg/ml into air pouches.
METHODS: Exudates were harvested after 3, 6, 24 and 48 h. Cell pellets and supernatants were used to determine the number of total leukocytes and neutrophils and to detect the production of several analytes by an antibody array approach, respectively. One-way analysis of variance was used for statistical analysis.
RESULTS: PAMAM dendrimers rapidly increased a leukocyte influx after 3 h, the vast majority of cells being neutrophils. This was also observed after 6 and 24 h, and resolution of inflammation was noted after 48 h. In general, the increased production of a greater number of analytes detected in the exudates after 6 h correlated with the number of dendrimer generations (G3 > G2 > G1 > G0).
CONCLUSIONS: PAMAM dendrimers devoid of any delivering molecules possess proinflammatory activities in vivo by themselves, probably via the production of different chemokines released by air pouch lining cells.

Entities:  

Keywords:  Chemokines; Inflammation; Leukocytes; Murine air pouch; Neutrophils; Polyamidoamine (PAMAM) dendrimer

Mesh:

Substances:

Year:  2016        PMID: 27338943     DOI: 10.1007/s00011-016-0959-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

1.  Activation of human neutrophils in vitro and dieldrin-induced neutrophilic inflammation in vivo.

Authors:  M Pelletier; C J Roberge; M Gauthier; K Vandal; P A Tessier; D Girard
Journal:  J Leukoc Biol       Date:  2001-09       Impact factor: 4.962

2.  Anti-inflammatory effect of Viscum album agglutinin-I (VAA-I): induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophilic inflammation in vivo.

Authors:  V Lavastre; H Cavalli; C Ratthe; D Girard
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

3.  Folate-functionalized dendrimers for targeting Chlamydia-infected tissues in a mouse model of reactive arthritis.

Authors:  Ilyes Benchaala; Manoj K Mishra; Susan M Wykes; Mirabela Hali; Rangaramanujam M Kannan; Judith A Whittum-Hudson
Journal:  Int J Pharm       Date:  2014-03-05       Impact factor: 5.875

4.  Effect of magnet implant on iron biodistribution of Fe@C nanoparticles in the mouse.

Authors:  Elvira Escribano; Rodrigo Fernández-Pacheco; J Gabriel Valdivia; M Ricardo Ibarra; Clara Marquina; Josep Queralt
Journal:  Arch Pharm Res       Date:  2012-02-02       Impact factor: 4.946

5.  The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers.

Authors:  Shaofei Wang; Yubin Li; Jiajun Fan; Ziyu Wang; Xian Zeng; Yun Sun; Ping Song; Dianwen Ju
Journal:  Biomaterials       Date:  2014-06-04       Impact factor: 12.479

6.  Titanium dioxide (TiO2) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivo.

Authors:  D M Gonçalves; D Girard
Journal:  Int Immunopharmacol       Date:  2011-03-21       Impact factor: 4.932

7.  In vivo efficacy of dendrimer-methylprednisolone conjugate formulation for the treatment of lung inflammation.

Authors:  R Inapagolla; B Raja Guru; Y E Kurtoglu; X Gao; M Lieh-Lai; D J P Bassett; R M Kannan
Journal:  Int J Pharm       Date:  2010-08-19       Impact factor: 5.875

8.  Cytotoxicity and in vitro characterization studies of synthesized Jeffamine-cored PAMAM dendrimers.

Authors:  Kıvılcım Oztürk; Ali Serol Ertürk; Can Sarısözen; Metin Tulu; Sema Calış
Journal:  J Microencapsul       Date:  2013-07-18       Impact factor: 3.142

9.  Intradermal air pouch leukocytosis as an in vivo test for nanoparticles.

Authors:  Jennifer Vandooren; Nele Berghmans; Chris Dillen; Ilse Van Aelst; Isabelle Ronsse; Liron Limor Israel; Ina Rosenberger; Jörg Kreuter; Jean-Paul Lellouche; Shulamit Michaeli; Erica Locatelli; Mauro Comes Franchini; Miren K Aiertza; Laura Sánchez-Abella; Iraida Loinaz; Dylan R Edwards; Louis Shenkman; Ghislain Opdenakker
Journal:  Int J Nanomedicine       Date:  2013-12-13

10.  In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate.

Authors:  Łukasz Uram; Magdalena Szuster; Krzysztof Gargasz; Aleksandra Filipowicz; Elżbieta Wałajtys-Rode; Stanisław Wołowiec
Journal:  Int J Nanomedicine       Date:  2013-12-11
View more
  11 in total

Review 1.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

2.  Evaluating the Apoptotic Cell Death Modulatory Activity of Nanoparticles in Men and Women Neutrophils and Eosinophils.

Authors:  Marion Vanharen; Isabelle Durocher; Abdelaziz Saafane; Denis Girard
Journal:  Inflammation       Date:  2021-09-18       Impact factor: 4.092

Review 3.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

4.  Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (-) nanoparticles.

Authors:  Isabelle Durocher; Claudie Noël; Valérie Lavastre; Denis Girard
Journal:  Inflamm Res       Date:  2017-07-04       Impact factor: 4.575

Review 5.  Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.

Authors:  Pratap C Naha; Sourav P Mukherjee; Hugh J Byrne
Journal:  Int J Environ Res Public Health       Date:  2018-02-14       Impact factor: 3.390

Review 6.  Immunotoxicity Considerations for Next Generation Cancer Nanomedicines.

Authors:  Gary Hannon; Joanne Lysaght; Neill J Liptrott; Adriele Prina-Mello
Journal:  Adv Sci (Weinh)       Date:  2019-08-01       Impact factor: 16.806

Review 7.  Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications.

Authors:  Ana Santos; Francisco Veiga; Ana Figueiras
Journal:  Materials (Basel)       Date:  2019-12-21       Impact factor: 3.623

Review 8.  Applications and Limitations of Dendrimers in Biomedicine.

Authors:  Adriana Aurelia Chis; Carmen Dobrea; Claudiu Morgovan; Anca Maria Arseniu; Luca Liviu Rus; Anca Butuca; Anca Maria Juncan; Maria Totan; Andreea Loredana Vonica-Tincu; Gabriela Cormos; Andrei Catalin Muntean; Maria Lucia Muresan; Felicia Gabriela Gligor; Adina Frum
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

9.  Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways.

Authors:  Hadeel Kheraldine; Ishita Gupta; Hashim Alhussain; Aayesha Jabeen; Farhan S Cyprian; Saghir Akhtar; Ala-Eddin Al Moustafa; Ousama Rachid
Journal:  Comput Struct Biotechnol J       Date:  2021-05-07       Impact factor: 7.271

Review 10.  Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles.

Authors:  Séverine Fruchon; Rémy Poupot
Journal:  Nanomaterials (Basel)       Date:  2017-09-01       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.